Advertisement

Index by author

November 01, 1992; Volume 263,Issue 2

A

  1. Aagaard, P J

    1. Binding and functional selectivity of himbacine for cloned and neuronal muscarinic receptors.
      J H Miller, P J Aagaard, V A Gibson and M McKinney
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 663-667;

  2. Abram, T S

    1. A second cysteinyl leukotriene receptor in human lung.
      C Labat, J L Ortiz, X Norel, I Gorenne, J Verley, T S Abram, N J Cuthbert, S R Tudhope, P Norman and P Gardiner
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 800-805;

  3. Acker, G M

    1. Activation of an epithelial neurokinin NK-1 receptor induces relaxation of rat trachea through release of prostaglandin E2.
      P Devillier, G M Acker, C Advenier, J Marsac, D Regoli and N Frossard
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 767-772;

  4. Advenier, C

    1. Activation of an epithelial neurokinin NK-1 receptor induces relaxation of rat trachea through release of prostaglandin E2.
      P Devillier, G M Acker, C Advenier, J Marsac, D Regoli and N Frossard
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 767-772;

  5. Ahrén, B

    1. Effects of tacrine on insulin secretion and 86Rb+ and 45Ca++ efflux from rat pancreatic islets.
      S Karlsson and B Ahrén
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 494-498;

  6. Albuquerque, E X

    1. Ontogeny of N-methyl-D-aspartate-induced current in cultured hippocampal neurons.
      H Ujihara and E X Albuquerque
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 859-867;
    2. Developmental change of the inhibition by lead of NMDA-activated currents in cultured hippocampal neurons.
      H Ujihara and E X Albuquerque
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 868-875;

  7. Alper, G

    1. Hemodynamic and sedative effects of dexmedetomidine in dog.
      B C Bloor, M Frankland, G Alper, D Raybould, J Weitz and M Shurtliff
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 690-697;

  8. Arbilla, S

    1. Comparative in vivo and in vitro regional selectivity of central omega (benzodiazepine) site ligands in inhibiting [3H]flumazenil binding in the rat central nervous system.
      J Benavides, B Peny, A Durand, S Arbilla and B Scatton
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 884-896;

  9. Arunachalam, K D

    1. Intrathecal St-587: effects on nociceptive reflexes and blood pressure in the rat.
      C W Loomis and K D Arunachalam
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 428-435;

  10. Atkinson, A J

    1. Kinetic analysis of P-glycoprotein-mediated doxorubicin efflux.
      M S Dordal, J N Winter and A J Atkinson
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 762-766;

  11. Aulakh, C S

    1. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats.
      C S Aulakh, J L Hill and D L Murphy
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 588-595;

B

  1. Benavides, J

    1. Comparative in vivo and in vitro regional selectivity of central omega (benzodiazepine) site ligands in inhibiting [3H]flumazenil binding in the rat central nervous system.
      J Benavides, B Peny, A Durand, S Arbilla and B Scatton
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 884-896;

  2. Béréziat, G

    1. Polymorphism of dextromethorphan metabolism: relationships between phenotype, genotype and response to the administration of encainide in humans.
      C Funck-Brentano, G Thomas, E Jacqz-Aigrain, J M Poirier, T Simon, G Béréziat and P Jaillon
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 780-786;

  3. Berrino, L

    1. Antiflammins suppress the A23187- and arachidonic acid-dependent chloride secretion in rabbit distal colonic mucosa.
      V Calderaro, C Parrillo, A Giovane, R Greco, M G Matera, L Berrino and F Rossi
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 579-587;

  4. Blackbourn, D J

    1. Effects of in vivo and in vitro administration of morphine sulfate upon rhesus macaque polymorphonuclear cell phagocytosis and chemotaxis.
      Y Liu, D J Blackbourn, L F Chuang, K F Killam and R Y Chuang
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 533-539;

  5. Bloor, B C

    1. Hemodynamic and sedative effects of dexmedetomidine in dog.
      B C Bloor, M Frankland, G Alper, D Raybould, J Weitz and M Shurtliff
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 690-697;

  6. Boer, P

    1. Amiloride-sensitive lithium reabsorption in rats: a micropuncture study.
      R Fransen, W H Boer, P Boer and H A Koomans
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 646-650;

  7. Boer, W H

    1. Amiloride-sensitive lithium reabsorption in rats: a micropuncture study.
      R Fransen, W H Boer, P Boer and H A Koomans
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 646-650;

  8. Bohmaker, K

    1. Comparative effects of receptor inactivation, 17 beta-estradiol and pertussis toxin on dopaminergic inhibition of prolactin secretion in vitro.
      E Meller, T Puza, J Diamond, H D Lieu and K Bohmaker
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 462-469;

  9. Bollinger-Gruber, J A

    1. Somatostatin depleting potency of cysteamine-related thiols and amines in the rat: structure-activity relation.
      S Szabo, S Reichlin, J A Bollinger-Gruber and A Brown
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 752-756;

  10. Boom, S P

    1. Organic cation transport and cationic drug interactions in freshly isolated proximal tubular cells of the rat.
      S P Boom, F W Gribnau and F G Russel
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 445-450;

  11. Bost, K L

    1. Characterization of antisera to the naloxone-insensitive receptor for beta-endorphin on U937 cells generated by using the complementary peptide strategy.
      N A Shahabi, K L Bost, T C Madhok and B M Sharp
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 876-883;

  12. Boulom, K

    1. Prolonged stimulation of bovine adrenal chromaffin cells with arachidonic acid and prostaglandin E2 increases expression of the proenkephalin gene and the secretion of [Met5]-enkephalin.
      H H Suh, P Hudson, R Fannin, K Boulom, M K McMillian, A M Poisner and J S Hong
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 527-532;

  13. Branch, C A

    1. Cardiovascular responses to cocaine are initially mediated by the central nervous system in rats.
      M M Knuepfer and C A Branch
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 734-741;
    2. Adrenergic mechanisms underlying cardiac and vascular responses to cocaine in conscious rats.
      C A Branch and M M Knuepfer
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 742-751;

  14. Brooks, D P

    1. Effect of captopril and the nonpeptide angiotensin II antagonists, SK&F 108566 and EXP3174, on renal function in dogs with a renal artery stenosis.
      D P Brooks, P D DePalma and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 422-427;

  15. Brown, A

    1. Somatostatin depleting potency of cysteamine-related thiols and amines in the rat: structure-activity relation.
      S Szabo, S Reichlin, J A Bollinger-Gruber and A Brown
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 752-756;

  16. Brown, D R

    1. Norepinephrine and alpha-2 adrenoceptors modulate active ion transport in porcine small intestine.
      K R Hildebrand and D R Brown
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 510-519;

  17. Burke, T F

    1. Effects of acute administration of alcohol on in vivo binding of [3H]Ro 15-1788 to mouse brain.
      M Mosaddeghi, T F Burke and J M Moerschbaecher
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 639-645;

C

  1. Calderaro, V

    1. Antiflammins suppress the A23187- and arachidonic acid-dependent chloride secretion in rabbit distal colonic mucosa.
      V Calderaro, C Parrillo, A Giovane, R Greco, M G Matera, L Berrino and F Rossi
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 579-587;

  2. Camden, J M

    1. Potentiation of cyclic adenosine monophosphate production by thrombin in the human erythroleukemia cell line, HEL.
      J T Turner, J M Camden, S Kansra, D Shelton-James, H Wu and S P Halenda
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 708-716;

  3. Capasso, A

    1. Dexamethasone prevents epileptiform activity induced by morphine in in vivo and in vitro experiments.
      S Pieretti, A Di Giannuario, A Loizzo, S Sagratella, A Scotti de Carolis, A Capasso and L Sorrentino
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 830-839;

  4. Carruba, M O

    1. Biochemical and functional identification of a novel dopamine receptor subtype in rat brown adipose tissue. Its role in modulating sympathetic stimulation-induced thermogenesis.
      E Nisoli, C Tonello, M Memo and M O Carruba
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 823-829;

  5. Chaki, K

    1. Antinociceptive mechanisms of [D-Arg2]-dermorphin tripeptide analogs.
      S Sakurada, K Chaki, H Watanabe, N Nakata, T Sakurada, K Kisara and K Suzuki
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 793-799;

  6. Chang, C

    1. Characterization of the rate-dependent effects of ethmozine on conduction, in vivo, and on the sodium current, in vitro, in the newborn heart.
      W Liu, C W Clarkson, S Yamasaki, C Chang, A Stolfi and A S Pickoff
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 608-616;

  7. Chaudhuri, G

    1. The pharmacological activity of nitroxyl: a potent vasodilator with activity similar to nitric oxide and/or endothelium-derived relaxing factor.
      J M Fukuto, K Chiang, R Hszieh, P Wong and G Chaudhuri
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 546-551;

  8. Chen, L L

    1. General anesthetics potentiate gamma-aminobutyric acid actions on gamma-aminobutyric acidA receptors expressed by Xenopus oocytes: lack of involvement of intracellular calcium.
      L H Lin, L L Chen, J A Zirrolli and R A Harris
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 569-578;

  9. Chiang, K

    1. The pharmacological activity of nitroxyl: a potent vasodilator with activity similar to nitric oxide and/or endothelium-derived relaxing factor.
      J M Fukuto, K Chiang, R Hszieh, P Wong and G Chaudhuri
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 546-551;

  10. Chiba, S

    1. Vascular alpha-1 antagonistic and agonistic effects of beta adrenoceptor agonists in rabbit common carotid arteries.
      T Fujiwara and S Chiba
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 457-461;
    2. Blocking effects of V1 (OPC-21268) and V2 (OPC-31260) antagonists on the negative inotropic response to vasopressin in isolated dog heart preparations.
      Y Furukawa, S Takayama, L M Ren, S Sawaki, Y Inoue and S Chiba
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 627-631;

  11. Chuang, L F

    1. Effects of in vivo and in vitro administration of morphine sulfate upon rhesus macaque polymorphonuclear cell phagocytosis and chemotaxis.
      Y Liu, D J Blackbourn, L F Chuang, K F Killam and R Y Chuang
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 533-539;

  12. Chuang, R Y

    1. Effects of in vivo and in vitro administration of morphine sulfate upon rhesus macaque polymorphonuclear cell phagocytosis and chemotaxis.
      Y Liu, D J Blackbourn, L F Chuang, K F Killam and R Y Chuang
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 533-539;

  13. Clarkson, C W

    1. Characterization of the rate-dependent effects of ethmozine on conduction, in vivo, and on the sodium current, in vitro, in the newborn heart.
      W Liu, C W Clarkson, S Yamasaki, C Chang, A Stolfi and A S Pickoff
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 608-616;

  14. Cornfield, L J

    1. [3H]2-phenylaminoadenosine ([3H]CV 1808) labels a novel adenosine receptor in rat brain.
      L J Cornfield, S Hu, S D Hurt and M A Sills
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 552-561;

  15. Craft, R M

    1. Intermediate efficacy mu opioids: examination of their morphine-like stimulus effects and response rate-decreasing effects in morphine-tolerant rats.
      M J Picker, R M Craft, S S Negus, K R Powell, S R Mattox, S R Jones, B K Hargrove and L A Dykstra
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 668-681;

  16. Crass, D

    1. Effect of the dopamine D2 receptor agonist quinpirole on renal sympathetic nerve activity and renal norepinephrine spillover in anesthetized rabbits.
      B Szabo, D Crass and K Starke
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 806-815;

  17. Cuthbert, N J

    1. A second cysteinyl leukotriene receptor in human lung.
      C Labat, J L Ortiz, X Norel, I Gorenne, J Verley, T S Abram, N J Cuthbert, S R Tudhope, P Norman and P Gardiner
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 800-805;

  18. Czubryt, M P

    1. Effect of chronic administration of verapamil on Ca++ channel density in rat tissue.
      B B Lonsberry, M P Czubryt, D F Dubo, J S Gilchrist, J C Docherty, T G Maddaford and G N Pierce
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 540-545;

D

  1. De Boer, T

    1. Characterization of the inhibitory effect of adrenocorticotropin/melanocyte-stimulating hormone-like peptides on the binding of dopamine receptor ligands to the dopamine D2 receptor in vitro.
      W J Florijn, T De Boer, J A Tonnaer and D H Versteeg
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 787-792;

  2. DePalma, P D

    1. Effect of captopril and the nonpeptide angiotensin II antagonists, SK&F 108566 and EXP3174, on renal function in dogs with a renal artery stenosis.
      D P Brooks, P D DePalma and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 422-427;

  3. Derrick, B E

    1. Mu opioid receptors are associated with the induction of hippocampal mossy fiber long-term potentiation.
      B E Derrick, S B Rodriguez, D N Lieberman and J L Martinez
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 725-733;

  4. Devillier, P

    1. Activation of an epithelial neurokinin NK-1 receptor induces relaxation of rat trachea through release of prostaglandin E2.
      P Devillier, G M Acker, C Advenier, J Marsac, D Regoli and N Frossard
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 767-772;

  5. Diamond, J

    1. Comparative effects of receptor inactivation, 17 beta-estradiol and pertussis toxin on dopaminergic inhibition of prolactin secretion in vitro.
      E Meller, T Puza, J Diamond, H D Lieu and K Bohmaker
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 462-469;

  6. Di Giannuario, A

    1. Dexamethasone prevents epileptiform activity induced by morphine in in vivo and in vitro experiments.
      S Pieretti, A Di Giannuario, A Loizzo, S Sagratella, A Scotti de Carolis, A Capasso and L Sorrentino
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 830-839;

  7. Docherty, J C

    1. Effect of chronic administration of verapamil on Ca++ channel density in rat tissue.
      B B Lonsberry, M P Czubryt, D F Dubo, J S Gilchrist, J C Docherty, T G Maddaford and G N Pierce
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 540-545;

  8. Dordal, M S

    1. Kinetic analysis of P-glycoprotein-mediated doxorubicin efflux.
      M S Dordal, J N Winter and A J Atkinson
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 762-766;

  9. Dubo, D F

    1. Effect of chronic administration of verapamil on Ca++ channel density in rat tissue.
      B B Lonsberry, M P Czubryt, D F Dubo, J S Gilchrist, J C Docherty, T G Maddaford and G N Pierce
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 540-545;

  10. Durand, A

    1. Comparative in vivo and in vitro regional selectivity of central omega (benzodiazepine) site ligands in inhibiting [3H]flumazenil binding in the rat central nervous system.
      J Benavides, B Peny, A Durand, S Arbilla and B Scatton
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 884-896;

  11. Dykstra, L A

    1. Intermediate efficacy mu opioids: examination of their morphine-like stimulus effects and response rate-decreasing effects in morphine-tolerant rats.
      M J Picker, R M Craft, S S Negus, K R Powell, S R Mattox, S R Jones, B K Hargrove and L A Dykstra
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 668-681;

E

  1. Ellingboe, J

    1. Acute effects of cocaine on plasma adrenocorticotropic hormone, luteinizing hormone and prolactin levels in cocaine-dependent men.
      J H Mendelson, S K Teoh, N K Mello, J Ellingboe and E Rhoades
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 505-509;

F

  1. Fannin, R

    1. Prolonged stimulation of bovine adrenal chromaffin cells with arachidonic acid and prostaglandin E2 increases expression of the proenkephalin gene and the secretion of [Met5]-enkephalin.
      H H Suh, P Hudson, R Fannin, K Boulom, M K McMillian, A M Poisner and J S Hong
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 527-532;

  2. Fernhout, B J

    1. Differential actions of corticotropin releasing factor on basolateral and central amygdaloid neurones, in vitro.
      D G Rainnie, B J Fernhout and P Shinnick-Gallagher
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 846-858;

  3. Feuerstein, T J

    1. Inhibitory effects of the antiparkinsonian drugs memantine and amantadine on N-methyl-D-aspartate-evoked acetylcholine release in the rabbit caudate nucleus in vitro.
      A Lupp, C H Lücking, R Koch, R Jackisch and T J Feuerstein
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 717-724;

  4. Florijn, W J

    1. Characterization of the inhibitory effect of adrenocorticotropin/melanocyte-stimulating hormone-like peptides on the binding of dopamine receptor ligands to the dopamine D2 receptor in vitro.
      W J Florijn, T De Boer, J A Tonnaer and D H Versteeg
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 787-792;

  5. France, C P

    1. Tolerance to the cataleptic effect of the N-methyl-D-aspartate (NMDA) receptor antagonists in pigeons: cross-tolerance between PCP-like compounds and competitive NMDA antagonists.
      Y Lu, C P France and J H Woods
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 499-504;

  6. Frankland, M

    1. Hemodynamic and sedative effects of dexmedetomidine in dog.
      B C Bloor, M Frankland, G Alper, D Raybould, J Weitz and M Shurtliff
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 690-697;

  7. Fransen, R

    1. Amiloride-sensitive lithium reabsorption in rats: a micropuncture study.
      R Fransen, W H Boer, P Boer and H A Koomans
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 646-650;

  8. Friedmann, T

    1. Functional analysis of brain dopamine systems in a genetic mouse model of Lesch-Nyhan syndrome.
      H A Jinnah, P J Langlais and T Friedmann
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 596-607;

  9. Frossard, N

    1. Activation of an epithelial neurokinin NK-1 receptor induces relaxation of rat trachea through release of prostaglandin E2.
      P Devillier, G M Acker, C Advenier, J Marsac, D Regoli and N Frossard
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 767-772;

  10. Fujiwara, T

    1. Vascular alpha-1 antagonistic and agonistic effects of beta adrenoceptor agonists in rabbit common carotid arteries.
      T Fujiwara and S Chiba
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 457-461;

  11. Fukuto, J M

    1. The pharmacological activity of nitroxyl: a potent vasodilator with activity similar to nitric oxide and/or endothelium-derived relaxing factor.
      J M Fukuto, K Chiang, R Hszieh, P Wong and G Chaudhuri
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 546-551;

  12. Funck-Brentano, C

    1. Polymorphism of dextromethorphan metabolism: relationships between phenotype, genotype and response to the administration of encainide in humans.
      C Funck-Brentano, G Thomas, E Jacqz-Aigrain, J M Poirier, T Simon, G Béréziat and P Jaillon
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 780-786;

  13. Furukawa, Y

    1. Blocking effects of V1 (OPC-21268) and V2 (OPC-31260) antagonists on the negative inotropic response to vasopressin in isolated dog heart preparations.
      Y Furukawa, S Takayama, L M Ren, S Sawaki, Y Inoue and S Chiba
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 627-631;

G

  1. Gardiner, P

    1. A second cysteinyl leukotriene receptor in human lung.
      C Labat, J L Ortiz, X Norel, I Gorenne, J Verley, T S Abram, N J Cuthbert, S R Tudhope, P Norman and P Gardiner
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 800-805;

  2. Ge, B L

    1. Characterization of [3H]morphine binding to interleukin-1-activated thymocytes.
      S Roy, B L Ge, H H Loh and N M Lee
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 451-456;

  3. Gerber, J G

    1. Differential effects of somatostatin and prostaglandins on gastric histamine release to pentagastrin.
      N A Payne and J G Gerber
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 520-526;

  4. Gibson, V A

    1. Binding and functional selectivity of himbacine for cloned and neuronal muscarinic receptors.
      J H Miller, P J Aagaard, V A Gibson and M McKinney
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 663-667;

  5. Gifford, A N

    1. Comparison of the role of local anesthetic properties with dopamine uptake blockade in the inhibition of striatal and nucleus accumbens [3H]acetylcholine release by cocaine.
      A N Gifford and K M Johnson
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 757-761;

  6. Gilchrist, J S

    1. Effect of chronic administration of verapamil on Ca++ channel density in rat tissue.
      B B Lonsberry, M P Czubryt, D F Dubo, J S Gilchrist, J C Docherty, T G Maddaford and G N Pierce
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 540-545;

  7. Giovane, A

    1. Antiflammins suppress the A23187- and arachidonic acid-dependent chloride secretion in rabbit distal colonic mucosa.
      V Calderaro, C Parrillo, A Giovane, R Greco, M G Matera, L Berrino and F Rossi
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 579-587;

  8. Goldfrank, L R

    1. Decreased plasma cholinesterase activity enhances cocaine toxicity in mice.
      R S Hoffman, G C Henry, P M Wax, R S Weisman, M A Howland and L R Goldfrank
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 698-702;

  9. Gorenne, I

    1. A second cysteinyl leukotriene receptor in human lung.
      C Labat, J L Ortiz, X Norel, I Gorenne, J Verley, T S Abram, N J Cuthbert, S R Tudhope, P Norman and P Gardiner
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 800-805;

  10. Greco, R

    1. Antiflammins suppress the A23187- and arachidonic acid-dependent chloride secretion in rabbit distal colonic mucosa.
      V Calderaro, C Parrillo, A Giovane, R Greco, M G Matera, L Berrino and F Rossi
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 579-587;

  11. Gribnau, F W

    1. Organic cation transport and cationic drug interactions in freshly isolated proximal tubular cells of the rat.
      S P Boom, F W Gribnau and F G Russel
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 445-450;

H

  1. Halenda, S P

    1. Potentiation of cyclic adenosine monophosphate production by thrombin in the human erythroleukemia cell line, HEL.
      J T Turner, J M Camden, S Kansra, D Shelton-James, H Wu and S P Halenda
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 708-716;

  2. Hargrove, B K

    1. Intermediate efficacy mu opioids: examination of their morphine-like stimulus effects and response rate-decreasing effects in morphine-tolerant rats.
      M J Picker, R M Craft, S S Negus, K R Powell, S R Mattox, S R Jones, B K Hargrove and L A Dykstra
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 668-681;

  3. Harris, R A

    1. General anesthetics potentiate gamma-aminobutyric acid actions on gamma-aminobutyric acidA receptors expressed by Xenopus oocytes: lack of involvement of intracellular calcium.
      L H Lin, L L Chen, J A Zirrolli and R A Harris
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 569-578;

  4. Henry, G C

    1. Decreased plasma cholinesterase activity enhances cocaine toxicity in mice.
      R S Hoffman, G C Henry, P M Wax, R S Weisman, M A Howland and L R Goldfrank
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 698-702;

  5. Herman, A G

    1. Selective M3 muscarinic receptor antagonists inhibit smooth muscle contraction in rabbit trachea without increasing the release of acetylcholine.
      B Loenders, M Rampart and A G Herman
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 773-779;

  6. Herzer, W A

    1. An experimental paradigm for investigating the role of endogenous adenosine/A1 receptor interactions in vivo.
      C J Kuan, W A Herzer and E K Jackson
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 657-662;

  7. Hildebrand, K R

    1. Norepinephrine and alpha-2 adrenoceptors modulate active ion transport in porcine small intestine.
      K R Hildebrand and D R Brown
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 510-519;

  8. Hill, J L

    1. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats.
      C S Aulakh, J L Hill and D L Murphy
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 588-595;

  9. Hirai, M

    1. Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1).
      Y Tanigawara, N Okamura, M Hirai, M Yasuhara, K Ueda, N Kioka, T Komano and R Hori
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 840-845;

  10. Hoffman, R S

    1. Decreased plasma cholinesterase activity enhances cocaine toxicity in mice.
      R S Hoffman, G C Henry, P M Wax, R S Weisman, M A Howland and L R Goldfrank
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 698-702;

  11. Hong, J S

    1. Prolonged stimulation of bovine adrenal chromaffin cells with arachidonic acid and prostaglandin E2 increases expression of the proenkephalin gene and the secretion of [Met5]-enkephalin.
      H H Suh, P Hudson, R Fannin, K Boulom, M K McMillian, A M Poisner and J S Hong
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 527-532;

  12. Hori, R

    1. Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1).
      Y Tanigawara, N Okamura, M Hirai, M Yasuhara, K Ueda, N Kioka, T Komano and R Hori
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 840-845;

  13. Howland, M A

    1. Decreased plasma cholinesterase activity enhances cocaine toxicity in mice.
      R S Hoffman, G C Henry, P M Wax, R S Weisman, M A Howland and L R Goldfrank
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 698-702;

  14. Hszieh, R

    1. The pharmacological activity of nitroxyl: a potent vasodilator with activity similar to nitric oxide and/or endothelium-derived relaxing factor.
      J M Fukuto, K Chiang, R Hszieh, P Wong and G Chaudhuri
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 546-551;

  15. Hu, S

    1. [3H]2-phenylaminoadenosine ([3H]CV 1808) labels a novel adenosine receptor in rat brain.
      L J Cornfield, S Hu, S D Hurt and M A Sills
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 552-561;

  16. Hudson, P

    1. Prolonged stimulation of bovine adrenal chromaffin cells with arachidonic acid and prostaglandin E2 increases expression of the proenkephalin gene and the secretion of [Met5]-enkephalin.
      H H Suh, P Hudson, R Fannin, K Boulom, M K McMillian, A M Poisner and J S Hong
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 527-532;

  17. Hurt, S D

    1. [3H]2-phenylaminoadenosine ([3H]CV 1808) labels a novel adenosine receptor in rat brain.
      L J Cornfield, S Hu, S D Hurt and M A Sills
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 552-561;

I

  1. Inoue, Y

    1. Blocking effects of V1 (OPC-21268) and V2 (OPC-31260) antagonists on the negative inotropic response to vasopressin in isolated dog heart preparations.
      Y Furukawa, S Takayama, L M Ren, S Sawaki, Y Inoue and S Chiba
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 627-631;

J

  1. Jackisch, R

    1. Inhibitory effects of the antiparkinsonian drugs memantine and amantadine on N-methyl-D-aspartate-evoked acetylcholine release in the rabbit caudate nucleus in vitro.
      A Lupp, C H Lücking, R Koch, R Jackisch and T J Feuerstein
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 717-724;

  2. Jackson, E K

    1. An experimental paradigm for investigating the role of endogenous adenosine/A1 receptor interactions in vivo.
      C J Kuan, W A Herzer and E K Jackson
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 657-662;

  3. Jacqz-Aigrain, E

    1. Polymorphism of dextromethorphan metabolism: relationships between phenotype, genotype and response to the administration of encainide in humans.
      C Funck-Brentano, G Thomas, E Jacqz-Aigrain, J M Poirier, T Simon, G Béréziat and P Jaillon
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 780-786;

  4. Jaillon, P

    1. Polymorphism of dextromethorphan metabolism: relationships between phenotype, genotype and response to the administration of encainide in humans.
      C Funck-Brentano, G Thomas, E Jacqz-Aigrain, J M Poirier, T Simon, G Béréziat and P Jaillon
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 780-786;

  5. Jinnah, H A

    1. Functional analysis of brain dopamine systems in a genetic mouse model of Lesch-Nyhan syndrome.
      H A Jinnah, P J Langlais and T Friedmann
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 596-607;

  6. Johnson, K M

    1. Comparison of the role of local anesthetic properties with dopamine uptake blockade in the inhibition of striatal and nucleus accumbens [3H]acetylcholine release by cocaine.
      A N Gifford and K M Johnson
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 757-761;

  7. Jones, S R

    1. Intermediate efficacy mu opioids: examination of their morphine-like stimulus effects and response rate-decreasing effects in morphine-tolerant rats.
      M J Picker, R M Craft, S S Negus, K R Powell, S R Mattox, S R Jones, B K Hargrove and L A Dykstra
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 668-681;

K

  1. Kalant, H

    1. Effects of chronic treatment with ethanol on the development of cross-tolerance to other alcohols and pentobarbital.
      A D Lê, J M Khanna and H Kalant
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 480-485;

  2. Kansra, S

    1. Potentiation of cyclic adenosine monophosphate production by thrombin in the human erythroleukemia cell line, HEL.
      J T Turner, J M Camden, S Kansra, D Shelton-James, H Wu and S P Halenda
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 708-716;

  3. Karim, O M

    1. Effect of pinacidil on the membrane electrical activity of guinea pig detrusor muscle.
      N Seki, O M Karim and J L Mostwin
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 816-822;

  4. Karlsson, S

    1. Effects of tacrine on insulin secretion and 86Rb+ and 45Ca++ efflux from rat pancreatic islets.
      S Karlsson and B Ahrén
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 494-498;

  5. Khanna, J M

    1. Effects of chronic treatment with ethanol on the development of cross-tolerance to other alcohols and pentobarbital.
      A D Lê, J M Khanna and H Kalant
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 480-485;

  6. Killam, K F

    1. Effects of in vivo and in vitro administration of morphine sulfate upon rhesus macaque polymorphonuclear cell phagocytosis and chemotaxis.
      Y Liu, D J Blackbourn, L F Chuang, K F Killam and R Y Chuang
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 533-539;

  7. Kioka, N

    1. Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1).
      Y Tanigawara, N Okamura, M Hirai, M Yasuhara, K Ueda, N Kioka, T Komano and R Hori
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 840-845;

  8. Kisara, K

    1. Antinociceptive mechanisms of [D-Arg2]-dermorphin tripeptide analogs.
      S Sakurada, K Chaki, H Watanabe, N Nakata, T Sakurada, K Kisara and K Suzuki
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 793-799;

  9. Knuepfer, M M

    1. Cardiovascular responses to cocaine are initially mediated by the central nervous system in rats.
      M M Knuepfer and C A Branch
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 734-741;
    2. Adrenergic mechanisms underlying cardiac and vascular responses to cocaine in conscious rats.
      C A Branch and M M Knuepfer
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 742-751;

  10. Koch, R

    1. Inhibitory effects of the antiparkinsonian drugs memantine and amantadine on N-methyl-D-aspartate-evoked acetylcholine release in the rabbit caudate nucleus in vitro.
      A Lupp, C H Lücking, R Koch, R Jackisch and T J Feuerstein
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 717-724;

  11. Komano, T

    1. Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1).
      Y Tanigawara, N Okamura, M Hirai, M Yasuhara, K Ueda, N Kioka, T Komano and R Hori
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 840-845;

  12. Koomans, H A

    1. Amiloride-sensitive lithium reabsorption in rats: a micropuncture study.
      R Fransen, W H Boer, P Boer and H A Koomans
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 646-650;

  13. Kuan, C J

    1. An experimental paradigm for investigating the role of endogenous adenosine/A1 receptor interactions in vivo.
      C J Kuan, W A Herzer and E K Jackson
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 657-662;

  14. Kunievsky, B

    1. Platelet-activating factor stimulates arachidonic acid release and enhances thromboxane B2 production in intact fetal rat brain ex vivo.
      B Kunievsky and E Yavin
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 562-568;

L

  1. Labat, C

    1. A second cysteinyl leukotriene receptor in human lung.
      C Labat, J L Ortiz, X Norel, I Gorenne, J Verley, T S Abram, N J Cuthbert, S R Tudhope, P Norman and P Gardiner
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 800-805;

  2. Langlais, P J

    1. Functional analysis of brain dopamine systems in a genetic mouse model of Lesch-Nyhan syndrome.
      H A Jinnah, P J Langlais and T Friedmann
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 596-607;

  3. Lê, A D

    1. Effects of chronic treatment with ethanol on the development of cross-tolerance to other alcohols and pentobarbital.
      A D Lê, J M Khanna and H Kalant
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 480-485;

  4. Lee, N M

    1. Characterization of [3H]morphine binding to interleukin-1-activated thymocytes.
      S Roy, B L Ge, H H Loh and N M Lee
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 451-456;

  5. Lieberman, D N

    1. Mu opioid receptors are associated with the induction of hippocampal mossy fiber long-term potentiation.
      B E Derrick, S B Rodriguez, D N Lieberman and J L Martinez
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 725-733;

  6. Lieu, H D

    1. Comparative effects of receptor inactivation, 17 beta-estradiol and pertussis toxin on dopaminergic inhibition of prolactin secretion in vitro.
      E Meller, T Puza, J Diamond, H D Lieu and K Bohmaker
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 462-469;

  7. Lin, L H

    1. General anesthetics potentiate gamma-aminobutyric acid actions on gamma-aminobutyric acidA receptors expressed by Xenopus oocytes: lack of involvement of intracellular calcium.
      L H Lin, L L Chen, J A Zirrolli and R A Harris
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 569-578;

  8. Liu, W

    1. Characterization of the rate-dependent effects of ethmozine on conduction, in vivo, and on the sodium current, in vitro, in the newborn heart.
      W Liu, C W Clarkson, S Yamasaki, C Chang, A Stolfi and A S Pickoff
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 608-616;

  9. Liu, Y

    1. Effects of in vivo and in vitro administration of morphine sulfate upon rhesus macaque polymorphonuclear cell phagocytosis and chemotaxis.
      Y Liu, D J Blackbourn, L F Chuang, K F Killam and R Y Chuang
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 533-539;
    2. Potentiation of adriamycin toxicity by ethanol in perfused rat liver.
      Y Liu and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 651-656;

  10. Loenders, B

    1. Selective M3 muscarinic receptor antagonists inhibit smooth muscle contraction in rabbit trachea without increasing the release of acetylcholine.
      B Loenders, M Rampart and A G Herman
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 773-779;

  11. Loh, H H

    1. Characterization of [3H]morphine binding to interleukin-1-activated thymocytes.
      S Roy, B L Ge, H H Loh and N M Lee
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 451-456;

  12. Loizzo, A

    1. Dexamethasone prevents epileptiform activity induced by morphine in in vivo and in vitro experiments.
      S Pieretti, A Di Giannuario, A Loizzo, S Sagratella, A Scotti de Carolis, A Capasso and L Sorrentino
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 830-839;

  13. Lonsberry, B B

    1. Effect of chronic administration of verapamil on Ca++ channel density in rat tissue.
      B B Lonsberry, M P Czubryt, D F Dubo, J S Gilchrist, J C Docherty, T G Maddaford and G N Pierce
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 540-545;

  14. Loomis, C W

    1. Intrathecal St-587: effects on nociceptive reflexes and blood pressure in the rat.
      C W Loomis and K D Arunachalam
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 428-435;

  15. Lu, Y

    1. Tolerance to the cataleptic effect of the N-methyl-D-aspartate (NMDA) receptor antagonists in pigeons: cross-tolerance between PCP-like compounds and competitive NMDA antagonists.
      Y Lu, C P France and J H Woods
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 499-504;

  16. Lücking, C H

    1. Inhibitory effects of the antiparkinsonian drugs memantine and amantadine on N-methyl-D-aspartate-evoked acetylcholine release in the rabbit caudate nucleus in vitro.
      A Lupp, C H Lücking, R Koch, R Jackisch and T J Feuerstein
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 717-724;

  17. Lupp, A

    1. Inhibitory effects of the antiparkinsonian drugs memantine and amantadine on N-methyl-D-aspartate-evoked acetylcholine release in the rabbit caudate nucleus in vitro.
      A Lupp, C H Lücking, R Koch, R Jackisch and T J Feuerstein
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 717-724;

M

  1. Maddaford, T G

    1. Effect of chronic administration of verapamil on Ca++ channel density in rat tissue.
      B B Lonsberry, M P Czubryt, D F Dubo, J S Gilchrist, J C Docherty, T G Maddaford and G N Pierce
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 540-545;

  2. Madhok, T C

    1. Characterization of antisera to the naloxone-insensitive receptor for beta-endorphin on U937 cells generated by using the complementary peptide strategy.
      N A Shahabi, K L Bost, T C Madhok and B M Sharp
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 876-883;

  3. Maeda, N

    1. Effect of FR121196, a novel cognitive enhancer, on the memory impairment of rats in passive avoidance and radial arm maze tasks.
      N Matsuoka, N Maeda, M Yamazaki, Y Ohkubo and I Yamaguchi
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 436-444;

  4. Marsac, J

    1. Activation of an epithelial neurokinin NK-1 receptor induces relaxation of rat trachea through release of prostaglandin E2.
      P Devillier, G M Acker, C Advenier, J Marsac, D Regoli and N Frossard
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 767-772;

  5. Martinez, J L

    1. Mu opioid receptors are associated with the induction of hippocampal mossy fiber long-term potentiation.
      B E Derrick, S B Rodriguez, D N Lieberman and J L Martinez
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 725-733;

  6. Matera, M G

    1. Antiflammins suppress the A23187- and arachidonic acid-dependent chloride secretion in rabbit distal colonic mucosa.
      V Calderaro, C Parrillo, A Giovane, R Greco, M G Matera, L Berrino and F Rossi
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 579-587;

  7. Matsuoka, N

    1. Effect of FR121196, a novel cognitive enhancer, on the memory impairment of rats in passive avoidance and radial arm maze tasks.
      N Matsuoka, N Maeda, M Yamazaki, Y Ohkubo and I Yamaguchi
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 436-444;

  8. Mattox, S R

    1. Intermediate efficacy mu opioids: examination of their morphine-like stimulus effects and response rate-decreasing effects in morphine-tolerant rats.
      M J Picker, R M Craft, S S Negus, K R Powell, S R Mattox, S R Jones, B K Hargrove and L A Dykstra
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 668-681;

  9. McKinney, M

    1. Binding and functional selectivity of himbacine for cloned and neuronal muscarinic receptors.
      J H Miller, P J Aagaard, V A Gibson and M McKinney
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 663-667;

  10. McLeskey, S W

    1. Propylbenzilylcholine mustard has greater specificity for muscarinic m2 receptors than for m3 receptors present in cerebellar granule cell culture from rat.
      S W McLeskey and W J Wojcik
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 703-707;

  11. McMillian, M K

    1. Prolonged stimulation of bovine adrenal chromaffin cells with arachidonic acid and prostaglandin E2 increases expression of the proenkephalin gene and the secretion of [Met5]-enkephalin.
      H H Suh, P Hudson, R Fannin, K Boulom, M K McMillian, A M Poisner and J S Hong
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 527-532;

  12. Meller, E

    1. Comparative effects of receptor inactivation, 17 beta-estradiol and pertussis toxin on dopaminergic inhibition of prolactin secretion in vitro.
      E Meller, T Puza, J Diamond, H D Lieu and K Bohmaker
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 462-469;

  13. Mello, N K

    1. Acute effects of cocaine on plasma adrenocorticotropic hormone, luteinizing hormone and prolactin levels in cocaine-dependent men.
      J H Mendelson, S K Teoh, N K Mello, J Ellingboe and E Rhoades
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 505-509;

  14. Memo, M

    1. Biochemical and functional identification of a novel dopamine receptor subtype in rat brown adipose tissue. Its role in modulating sympathetic stimulation-induced thermogenesis.
      E Nisoli, C Tonello, M Memo and M O Carruba
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 823-829;

  15. Mendelson, J H

    1. Acute effects of cocaine on plasma adrenocorticotropic hormone, luteinizing hormone and prolactin levels in cocaine-dependent men.
      J H Mendelson, S K Teoh, N K Mello, J Ellingboe and E Rhoades
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 505-509;

  16. Miller, J H

    1. Binding and functional selectivity of himbacine for cloned and neuronal muscarinic receptors.
      J H Miller, P J Aagaard, V A Gibson and M McKinney
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 663-667;

  17. Moerschbaecher, J M

    1. Effects of acute administration of alcohol on in vivo binding of [3H]Ro 15-1788 to mouse brain.
      M Mosaddeghi, T F Burke and J M Moerschbaecher
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 639-645;

  18. Mosaddeghi, M

    1. Effects of acute administration of alcohol on in vivo binding of [3H]Ro 15-1788 to mouse brain.
      M Mosaddeghi, T F Burke and J M Moerschbaecher
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 639-645;

  19. Mostwin, J L

    1. Effect of pinacidil on the membrane electrical activity of guinea pig detrusor muscle.
      N Seki, O M Karim and J L Mostwin
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 816-822;

  20. Murphy, D L

    1. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats.
      C S Aulakh, J L Hill and D L Murphy
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 588-595;

N

  1. Nakata, N

    1. Antinociceptive mechanisms of [D-Arg2]-dermorphin tripeptide analogs.
      S Sakurada, K Chaki, H Watanabe, N Nakata, T Sakurada, K Kisara and K Suzuki
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 793-799;

  2. Negus, S S

    1. Intermediate efficacy mu opioids: examination of their morphine-like stimulus effects and response rate-decreasing effects in morphine-tolerant rats.
      M J Picker, R M Craft, S S Negus, K R Powell, S R Mattox, S R Jones, B K Hargrove and L A Dykstra
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 668-681;

  3. Nisoli, E

    1. Biochemical and functional identification of a novel dopamine receptor subtype in rat brown adipose tissue. Its role in modulating sympathetic stimulation-induced thermogenesis.
      E Nisoli, C Tonello, M Memo and M O Carruba
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 823-829;

  4. Norel, X

    1. A second cysteinyl leukotriene receptor in human lung.
      C Labat, J L Ortiz, X Norel, I Gorenne, J Verley, T S Abram, N J Cuthbert, S R Tudhope, P Norman and P Gardiner
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 800-805;

  5. Norman, P

    1. A second cysteinyl leukotriene receptor in human lung.
      C Labat, J L Ortiz, X Norel, I Gorenne, J Verley, T S Abram, N J Cuthbert, S R Tudhope, P Norman and P Gardiner
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 800-805;

O

  1. Ohkubo, Y

    1. Effect of FR121196, a novel cognitive enhancer, on the memory impairment of rats in passive avoidance and radial arm maze tasks.
      N Matsuoka, N Maeda, M Yamazaki, Y Ohkubo and I Yamaguchi
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 436-444;

  2. Okamura, N

    1. Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1).
      Y Tanigawara, N Okamura, M Hirai, M Yasuhara, K Ueda, N Kioka, T Komano and R Hori
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 840-845;

  3. Ortiz, J L

    1. A second cysteinyl leukotriene receptor in human lung.
      C Labat, J L Ortiz, X Norel, I Gorenne, J Verley, T S Abram, N J Cuthbert, S R Tudhope, P Norman and P Gardiner
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 800-805;

P

  1. Paalzow, G H

    1. L-dopa induces opposing effects on pain in intact rats: (-)-sulpiride, SCH 23390 or alpha-methyl-DL-p-tyrosine methylester hydrochloride reveals profound hyperalgesia in large antinociceptive doses.
      G H Paalzow
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 470-479;

  2. Pardridge, W M

    1. Biotin delivery to brain with a covalent conjugate of avidin and a monoclonal antibody to the transferrin receptor.
      T Yoshikawa and W M Pardridge
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 897-903;

  3. Parrillo, C

    1. Antiflammins suppress the A23187- and arachidonic acid-dependent chloride secretion in rabbit distal colonic mucosa.
      V Calderaro, C Parrillo, A Giovane, R Greco, M G Matera, L Berrino and F Rossi
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 579-587;

  4. Payne, N A

    1. Differential effects of somatostatin and prostaglandins on gastric histamine release to pentagastrin.
      N A Payne and J G Gerber
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 520-526;

  5. Peny, B

    1. Comparative in vivo and in vitro regional selectivity of central omega (benzodiazepine) site ligands in inhibiting [3H]flumazenil binding in the rat central nervous system.
      J Benavides, B Peny, A Durand, S Arbilla and B Scatton
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 884-896;

  6. Picker, M J

    1. Intermediate efficacy mu opioids: examination of their morphine-like stimulus effects and response rate-decreasing effects in morphine-tolerant rats.
      M J Picker, R M Craft, S S Negus, K R Powell, S R Mattox, S R Jones, B K Hargrove and L A Dykstra
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 668-681;

  7. Pickoff, A S

    1. Characterization of the rate-dependent effects of ethmozine on conduction, in vivo, and on the sodium current, in vitro, in the newborn heart.
      W Liu, C W Clarkson, S Yamasaki, C Chang, A Stolfi and A S Pickoff
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 608-616;

  8. Pierce, G N

    1. Effect of chronic administration of verapamil on Ca++ channel density in rat tissue.
      B B Lonsberry, M P Czubryt, D F Dubo, J S Gilchrist, J C Docherty, T G Maddaford and G N Pierce
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 540-545;

  9. Pieretti, S

    1. Dexamethasone prevents epileptiform activity induced by morphine in in vivo and in vitro experiments.
      S Pieretti, A Di Giannuario, A Loizzo, S Sagratella, A Scotti de Carolis, A Capasso and L Sorrentino
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 830-839;

  10. Poirier, J M

    1. Polymorphism of dextromethorphan metabolism: relationships between phenotype, genotype and response to the administration of encainide in humans.
      C Funck-Brentano, G Thomas, E Jacqz-Aigrain, J M Poirier, T Simon, G Béréziat and P Jaillon
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 780-786;

  11. Poisner, A M

    1. Prolonged stimulation of bovine adrenal chromaffin cells with arachidonic acid and prostaglandin E2 increases expression of the proenkephalin gene and the secretion of [Met5]-enkephalin.
      H H Suh, P Hudson, R Fannin, K Boulom, M K McMillian, A M Poisner and J S Hong
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 527-532;

  12. Powell, K R

    1. Intermediate efficacy mu opioids: examination of their morphine-like stimulus effects and response rate-decreasing effects in morphine-tolerant rats.
      M J Picker, R M Craft, S S Negus, K R Powell, S R Mattox, S R Jones, B K Hargrove and L A Dykstra
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 668-681;

  13. Puza, T

    1. Comparative effects of receptor inactivation, 17 beta-estradiol and pertussis toxin on dopaminergic inhibition of prolactin secretion in vitro.
      E Meller, T Puza, J Diamond, H D Lieu and K Bohmaker
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 462-469;

R

  1. Rabin, R A

    1. Yohimbine as a serotonergic agent: evidence from receptor binding and drug discrimination.
      J C Winter and R A Rabin
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 682-689;

  2. Rainnie, D G

    1. Differential actions of corticotropin releasing factor on basolateral and central amygdaloid neurones, in vitro.
      D G Rainnie, B J Fernhout and P Shinnick-Gallagher
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 846-858;

  3. Rampart, M

    1. Selective M3 muscarinic receptor antagonists inhibit smooth muscle contraction in rabbit trachea without increasing the release of acetylcholine.
      B Loenders, M Rampart and A G Herman
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 773-779;

  4. Raybould, D

    1. Hemodynamic and sedative effects of dexmedetomidine in dog.
      B C Bloor, M Frankland, G Alper, D Raybould, J Weitz and M Shurtliff
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 690-697;

  5. Regoli, D

    1. Activation of an epithelial neurokinin NK-1 receptor induces relaxation of rat trachea through release of prostaglandin E2.
      P Devillier, G M Acker, C Advenier, J Marsac, D Regoli and N Frossard
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 767-772;

  6. Reichlin, S

    1. Somatostatin depleting potency of cysteamine-related thiols and amines in the rat: structure-activity relation.
      S Szabo, S Reichlin, J A Bollinger-Gruber and A Brown
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 752-756;

  7. Ren, L M

    1. Blocking effects of V1 (OPC-21268) and V2 (OPC-31260) antagonists on the negative inotropic response to vasopressin in isolated dog heart preparations.
      Y Furukawa, S Takayama, L M Ren, S Sawaki, Y Inoue and S Chiba
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 627-631;

  8. Reynolds, I J

    1. Interactions between zinc and spermidine on the N-methyl-D-aspartate receptor complex: clues to the mechanism of action of 1,10-bis(guanidino)decane and pentamidine.
      I J Reynolds
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 632-638;

  9. Rhoades, E

    1. Acute effects of cocaine on plasma adrenocorticotropic hormone, luteinizing hormone and prolactin levels in cocaine-dependent men.
      J H Mendelson, S K Teoh, N K Mello, J Ellingboe and E Rhoades
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 505-509;

  10. Rigdon, G C

    1. 5-Hydroxytryptamine 1a receptor agonists block prepulse inhibition of acoustic startle reflex.
      G C Rigdon and J K Weatherspoon
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 486-493;

  11. Rodriguez, S B

    1. Mu opioid receptors are associated with the induction of hippocampal mossy fiber long-term potentiation.
      B E Derrick, S B Rodriguez, D N Lieberman and J L Martinez
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 725-733;

  12. Rossi, F

    1. Antiflammins suppress the A23187- and arachidonic acid-dependent chloride secretion in rabbit distal colonic mucosa.
      V Calderaro, C Parrillo, A Giovane, R Greco, M G Matera, L Berrino and F Rossi
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 579-587;

  13. Roy, S

    1. Characterization of [3H]morphine binding to interleukin-1-activated thymocytes.
      S Roy, B L Ge, H H Loh and N M Lee
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 451-456;

  14. Ruffolo, R R

    1. Effect of captopril and the nonpeptide angiotensin II antagonists, SK&F 108566 and EXP3174, on renal function in dogs with a renal artery stenosis.
      D P Brooks, P D DePalma and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 422-427;

  15. Russel, F G

    1. Organic cation transport and cationic drug interactions in freshly isolated proximal tubular cells of the rat.
      S P Boom, F W Gribnau and F G Russel
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 445-450;

S

  1. Sagratella, S

    1. Dexamethasone prevents epileptiform activity induced by morphine in in vivo and in vitro experiments.
      S Pieretti, A Di Giannuario, A Loizzo, S Sagratella, A Scotti de Carolis, A Capasso and L Sorrentino
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 830-839;

  2. Sakurada, S

    1. Antinociceptive mechanisms of [D-Arg2]-dermorphin tripeptide analogs.
      S Sakurada, K Chaki, H Watanabe, N Nakata, T Sakurada, K Kisara and K Suzuki
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 793-799;

  3. Sakurada, T

    1. Antinociceptive mechanisms of [D-Arg2]-dermorphin tripeptide analogs.
      S Sakurada, K Chaki, H Watanabe, N Nakata, T Sakurada, K Kisara and K Suzuki
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 793-799;

  4. Sawaki, S

    1. Blocking effects of V1 (OPC-21268) and V2 (OPC-31260) antagonists on the negative inotropic response to vasopressin in isolated dog heart preparations.
      Y Furukawa, S Takayama, L M Ren, S Sawaki, Y Inoue and S Chiba
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 627-631;

  5. Scatton, B

    1. Comparative in vivo and in vitro regional selectivity of central omega (benzodiazepine) site ligands in inhibiting [3H]flumazenil binding in the rat central nervous system.
      J Benavides, B Peny, A Durand, S Arbilla and B Scatton
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 884-896;

  6. Scotti de Carolis, A

    1. Dexamethasone prevents epileptiform activity induced by morphine in in vivo and in vitro experiments.
      S Pieretti, A Di Giannuario, A Loizzo, S Sagratella, A Scotti de Carolis, A Capasso and L Sorrentino
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 830-839;

  7. Seidler, F J

    1. Fetal cocaine exposure causes persistent noradrenergic hyperactivity in rat brain regions: effects on neurotransmitter turnover and receptors.
      F J Seidler and T A Slotkin
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 413-421;

  8. Seki, N

    1. Effect of pinacidil on the membrane electrical activity of guinea pig detrusor muscle.
      N Seki, O M Karim and J L Mostwin
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 816-822;

  9. Shahabi, N A

    1. Characterization of antisera to the naloxone-insensitive receptor for beta-endorphin on U937 cells generated by using the complementary peptide strategy.
      N A Shahabi, K L Bost, T C Madhok and B M Sharp
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 876-883;

  10. Sharp, B M

    1. Characterization of antisera to the naloxone-insensitive receptor for beta-endorphin on U937 cells generated by using the complementary peptide strategy.
      N A Shahabi, K L Bost, T C Madhok and B M Sharp
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 876-883;

  11. Shelton-James, D

    1. Potentiation of cyclic adenosine monophosphate production by thrombin in the human erythroleukemia cell line, HEL.
      J T Turner, J M Camden, S Kansra, D Shelton-James, H Wu and S P Halenda
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 708-716;

  12. Shinnick-Gallagher, P

    1. Differential actions of corticotropin releasing factor on basolateral and central amygdaloid neurones, in vitro.
      D G Rainnie, B J Fernhout and P Shinnick-Gallagher
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 846-858;

  13. Shurtliff, M

    1. Hemodynamic and sedative effects of dexmedetomidine in dog.
      B C Bloor, M Frankland, G Alper, D Raybould, J Weitz and M Shurtliff
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 690-697;

  14. Sills, M A

    1. [3H]2-phenylaminoadenosine ([3H]CV 1808) labels a novel adenosine receptor in rat brain.
      L J Cornfield, S Hu, S D Hurt and M A Sills
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 552-561;

  15. Simon, T

    1. Polymorphism of dextromethorphan metabolism: relationships between phenotype, genotype and response to the administration of encainide in humans.
      C Funck-Brentano, G Thomas, E Jacqz-Aigrain, J M Poirier, T Simon, G Béréziat and P Jaillon
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 780-786;

  16. Slotkin, T A

    1. Fetal cocaine exposure causes persistent noradrenergic hyperactivity in rat brain regions: effects on neurotransmitter turnover and receptors.
      F J Seidler and T A Slotkin
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 413-421;

  17. Sorrentino, L

    1. Dexamethasone prevents epileptiform activity induced by morphine in in vivo and in vitro experiments.
      S Pieretti, A Di Giannuario, A Loizzo, S Sagratella, A Scotti de Carolis, A Capasso and L Sorrentino
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 830-839;

  18. Starke, K

    1. Effect of the dopamine D2 receptor agonist quinpirole on renal sympathetic nerve activity and renal norepinephrine spillover in anesthetized rabbits.
      B Szabo, D Crass and K Starke
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 806-815;

  19. Stolfi, A

    1. Characterization of the rate-dependent effects of ethmozine on conduction, in vivo, and on the sodium current, in vitro, in the newborn heart.
      W Liu, C W Clarkson, S Yamasaki, C Chang, A Stolfi and A S Pickoff
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 608-616;

  20. Suh, H H

    1. Prolonged stimulation of bovine adrenal chromaffin cells with arachidonic acid and prostaglandin E2 increases expression of the proenkephalin gene and the secretion of [Met5]-enkephalin.
      H H Suh, P Hudson, R Fannin, K Boulom, M K McMillian, A M Poisner and J S Hong
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 527-532;

  21. Suzuki, K

    1. Antinociceptive mechanisms of [D-Arg2]-dermorphin tripeptide analogs.
      S Sakurada, K Chaki, H Watanabe, N Nakata, T Sakurada, K Kisara and K Suzuki
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 793-799;

  22. Szabo, B

    1. Effect of the dopamine D2 receptor agonist quinpirole on renal sympathetic nerve activity and renal norepinephrine spillover in anesthetized rabbits.
      B Szabo, D Crass and K Starke
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 806-815;

  23. Szabo, S

    1. Somatostatin depleting potency of cysteamine-related thiols and amines in the rat: structure-activity relation.
      S Szabo, S Reichlin, J A Bollinger-Gruber and A Brown
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 752-756;

T

  1. Takayama, S

    1. Blocking effects of V1 (OPC-21268) and V2 (OPC-31260) antagonists on the negative inotropic response to vasopressin in isolated dog heart preparations.
      Y Furukawa, S Takayama, L M Ren, S Sawaki, Y Inoue and S Chiba
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 627-631;

  2. Tanigawara, Y

    1. Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1).
      Y Tanigawara, N Okamura, M Hirai, M Yasuhara, K Ueda, N Kioka, T Komano and R Hori
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 840-845;

  3. Teoh, S K

    1. Acute effects of cocaine on plasma adrenocorticotropic hormone, luteinizing hormone and prolactin levels in cocaine-dependent men.
      J H Mendelson, S K Teoh, N K Mello, J Ellingboe and E Rhoades
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 505-509;

  4. Thomas, G

    1. Polymorphism of dextromethorphan metabolism: relationships between phenotype, genotype and response to the administration of encainide in humans.
      C Funck-Brentano, G Thomas, E Jacqz-Aigrain, J M Poirier, T Simon, G Béréziat and P Jaillon
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 780-786;

  5. Thurman, R G

    1. Potentiation of adriamycin toxicity by ethanol in perfused rat liver.
      Y Liu and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 651-656;

  6. Tonello, C

    1. Biochemical and functional identification of a novel dopamine receptor subtype in rat brown adipose tissue. Its role in modulating sympathetic stimulation-induced thermogenesis.
      E Nisoli, C Tonello, M Memo and M O Carruba
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 823-829;

  7. Tonnaer, J A

    1. Characterization of the inhibitory effect of adrenocorticotropin/melanocyte-stimulating hormone-like peptides on the binding of dopamine receptor ligands to the dopamine D2 receptor in vitro.
      W J Florijn, T De Boer, J A Tonnaer and D H Versteeg
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 787-792;

  8. Tudhope, S R

    1. A second cysteinyl leukotriene receptor in human lung.
      C Labat, J L Ortiz, X Norel, I Gorenne, J Verley, T S Abram, N J Cuthbert, S R Tudhope, P Norman and P Gardiner
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 800-805;

  9. Turner, J T

    1. Potentiation of cyclic adenosine monophosphate production by thrombin in the human erythroleukemia cell line, HEL.
      J T Turner, J M Camden, S Kansra, D Shelton-James, H Wu and S P Halenda
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 708-716;

U

  1. Ueda, K

    1. Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1).
      Y Tanigawara, N Okamura, M Hirai, M Yasuhara, K Ueda, N Kioka, T Komano and R Hori
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 840-845;

  2. Ujihara, H

    1. Ontogeny of N-methyl-D-aspartate-induced current in cultured hippocampal neurons.
      H Ujihara and E X Albuquerque
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 859-867;
    2. Developmental change of the inhibition by lead of NMDA-activated currents in cultured hippocampal neurons.
      H Ujihara and E X Albuquerque
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 868-875;

V

  1. Verley, J

    1. A second cysteinyl leukotriene receptor in human lung.
      C Labat, J L Ortiz, X Norel, I Gorenne, J Verley, T S Abram, N J Cuthbert, S R Tudhope, P Norman and P Gardiner
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 800-805;

  2. Versteeg, D H

    1. Characterization of the inhibitory effect of adrenocorticotropin/melanocyte-stimulating hormone-like peptides on the binding of dopamine receptor ligands to the dopamine D2 receptor in vitro.
      W J Florijn, T De Boer, J A Tonnaer and D H Versteeg
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 787-792;

W

  1. Wagner, G C

    1. Motor impairments after methamphetamine-induced neurotoxicity in the rat.
      S L Walsh and G C Wagner
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 617-626;

  2. Walsh, S L

    1. Motor impairments after methamphetamine-induced neurotoxicity in the rat.
      S L Walsh and G C Wagner
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 617-626;

  3. Watanabe, H

    1. Antinociceptive mechanisms of [D-Arg2]-dermorphin tripeptide analogs.
      S Sakurada, K Chaki, H Watanabe, N Nakata, T Sakurada, K Kisara and K Suzuki
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 793-799;

  4. Wax, P M

    1. Decreased plasma cholinesterase activity enhances cocaine toxicity in mice.
      R S Hoffman, G C Henry, P M Wax, R S Weisman, M A Howland and L R Goldfrank
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 698-702;

  5. Weatherspoon, J K

    1. 5-Hydroxytryptamine 1a receptor agonists block prepulse inhibition of acoustic startle reflex.
      G C Rigdon and J K Weatherspoon
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 486-493;

  6. Weisman, R S

    1. Decreased plasma cholinesterase activity enhances cocaine toxicity in mice.
      R S Hoffman, G C Henry, P M Wax, R S Weisman, M A Howland and L R Goldfrank
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 698-702;

  7. Weitz, J

    1. Hemodynamic and sedative effects of dexmedetomidine in dog.
      B C Bloor, M Frankland, G Alper, D Raybould, J Weitz and M Shurtliff
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 690-697;

  8. Winter, J C

    1. Yohimbine as a serotonergic agent: evidence from receptor binding and drug discrimination.
      J C Winter and R A Rabin
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 682-689;

  9. Winter, J N

    1. Kinetic analysis of P-glycoprotein-mediated doxorubicin efflux.
      M S Dordal, J N Winter and A J Atkinson
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 762-766;

  10. Wojcik, W J

    1. Propylbenzilylcholine mustard has greater specificity for muscarinic m2 receptors than for m3 receptors present in cerebellar granule cell culture from rat.
      S W McLeskey and W J Wojcik
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 703-707;

  11. Wong, P

    1. The pharmacological activity of nitroxyl: a potent vasodilator with activity similar to nitric oxide and/or endothelium-derived relaxing factor.
      J M Fukuto, K Chiang, R Hszieh, P Wong and G Chaudhuri
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 546-551;

  12. Woods, J H

    1. Tolerance to the cataleptic effect of the N-methyl-D-aspartate (NMDA) receptor antagonists in pigeons: cross-tolerance between PCP-like compounds and competitive NMDA antagonists.
      Y Lu, C P France and J H Woods
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 499-504;

  13. Wu, H

    1. Potentiation of cyclic adenosine monophosphate production by thrombin in the human erythroleukemia cell line, HEL.
      J T Turner, J M Camden, S Kansra, D Shelton-James, H Wu and S P Halenda
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 708-716;

Y

  1. Yamaguchi, I

    1. Effect of FR121196, a novel cognitive enhancer, on the memory impairment of rats in passive avoidance and radial arm maze tasks.
      N Matsuoka, N Maeda, M Yamazaki, Y Ohkubo and I Yamaguchi
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 436-444;

  2. Yamasaki, S

    1. Characterization of the rate-dependent effects of ethmozine on conduction, in vivo, and on the sodium current, in vitro, in the newborn heart.
      W Liu, C W Clarkson, S Yamasaki, C Chang, A Stolfi and A S Pickoff
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 608-616;

  3. Yamazaki, M

    1. Effect of FR121196, a novel cognitive enhancer, on the memory impairment of rats in passive avoidance and radial arm maze tasks.
      N Matsuoka, N Maeda, M Yamazaki, Y Ohkubo and I Yamaguchi
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 436-444;

  4. Yasuhara, M

    1. Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1).
      Y Tanigawara, N Okamura, M Hirai, M Yasuhara, K Ueda, N Kioka, T Komano and R Hori
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 840-845;

  5. Yavin, E

    1. Platelet-activating factor stimulates arachidonic acid release and enhances thromboxane B2 production in intact fetal rat brain ex vivo.
      B Kunievsky and E Yavin
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 562-568;

  6. Yoshikawa, T

    1. Biotin delivery to brain with a covalent conjugate of avidin and a monoclonal antibody to the transferrin receptor.
      T Yoshikawa and W M Pardridge
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 897-903;

Z

  1. Zirrolli, J A

    1. General anesthetics potentiate gamma-aminobutyric acid actions on gamma-aminobutyric acidA receptors expressed by Xenopus oocytes: lack of involvement of intracellular calcium.
      L H Lin, L L Chen, J A Zirrolli and R A Harris
      Journal of Pharmacology and Experimental Therapeutics November 1992, 263 (2) 569-578;
Back to top

In this issue